Skip to main content

Advertisement

We’d like to understand how you use our websites in order to improve them. Register your interest.
Download PDF

In vitro three-dimensional modeling of fallopian tube secretory epithelial cells

BMC Cell Biology volume 14, Article number: 43 (2013) Cite this article

Abstract

Background

Fallopian tube secretory epithelial cells (FTSECs) have been implicated as a cell-of-origin for high-grade serous epithelial ovarian cancer. However, there are relatively few in vitro models of this tissue type available for use in studies of FTSEC biology and malignant transformation. In vitro three-dimensional (3D) cell culture models aim to recreate the architecture and geometry of tissues in vivo and restore the complex network of cell-cell/cell-matrix interactions that occur throughout the surface of the cell membrane.

Results

We have established and characterized 3D spheroid culture models of primary FTSECs. FTSEC spheroids contain central cores of hyaline matrix surrounded by mono- or multi-layer epithelial sheets. We found that 3D culturing alters the molecular characteristics of FTSECs compared to 2D cultures of the same cells. Gene expression profiling identified more than a thousand differentially expressed genes between 3D and 2D cultures of the same FTSEC lines. Pathways significantly under-represented in 3D FTSEC cultures were associated with cell cycle progression and DNA replication. This was also reflected in the reduced proliferative indices observed in 3D spheroids stained for the proliferation marker MIB1. Comparisons with gene expression profiles of fresh fallopian tube tissues revealed that 2D FTSEC cultures clustered with follicular phase tubal epithelium, whereas 3D FTSEC cultures clustered with luteal phase samples.

Conclusions

This 3D model of fallopian tube secretory epithelial cells will advance our ability to study the underlying biology and etiology of fallopian tube tissues and the pathogenesis of high-grade serous epithelial ovarian cancer.

Background

The human fallopian tube is lined by a simple columnar epithelium consisting of both ciliated and secretory epithelial cells. Fallopian tube secretory epithelial cells (FTSECs) are of particular interest given their proposed role as a precursor tissue for high-grade serous epithelial ovarian cancers, which is the most common ovarian cancer histological subtype [1, 2]. However, the biology of FTSECs remains poorly understood. This is partly due to difficulties in accessing normal primary FTSECs and in the subsequent development of in vitro models of this tissue type. Primary FTSECs have proved challenging to culture, reportedly loosing expression of differentiated markers when propagated in vitro. This indicates a cellular plasticity that is strongly influenced by culture conditions [3]. Recent advances in ex vivo culture of fallopian epithelia have been achieved by plating the cells onto collagen matrices [4, 5]. Under these conditions lineage and differentiation markers are maintained, but unfortunately the cells have an limited capacity for proliferation and cannot be sub-cultured without being immortalized or transformed [6].

Current evidence suggests that FTSECs are a likely origin of high-grade serous epithelial ovarian cancers (HGSOCs) [1, 2]. The biological characteristics of the cell-of -origin for different cancers are likely to influence the etiology of the malignant disease [7], including the somatic genetic events that occur during neoplastic development. Gaining a better understanding of the initiation and early stage development of HGSOCs is likely to be of clinical importance. The majority of epithelial ovarian tumors are diagnosed at the late stages (stage III/IV) when 5-year survival rates are only ~30%. In contrast, patients diagnosed with stage I disease have survival rates of over 90%, and are often cured by surgical intervention. The ability to detect HGSOCs in the earliest stages would represent a realistic approach to reducing mortality and a better understanding of the role of FTSECs in the initiation of HGSOCs may be key to the discovery of novel biomarkers associated with early stage disease.

Although the basic functions of all epithelia are the same, there are many fundamental differences in cell morphology, cell function and gene expression across the epithelial cells of different organs. Regardless of cell type, classical cell culture techniques typically involve culturing cells on plastic surfaces that bear limited resemblance to the organs from which the cells originate. Traditional two-dimensional (2D) in vitro techniques loose the architecture and geometrical features of tissues in vivo, as well as the gradients of nutrients, oxygen, carbon dioxide and other factors that characterize these tissues. Seminal work in three-dimensional (3D) modeling by Bissell and colleagues has shown that culturing normal breast epithelial cells in 3D can induce gland formation, restore cellular polarity and induce upregulated expression of biologically active molecules, thereby simulating the in vivo environment [8–10]. Similar approaches have since been used for other epithelial cell types. In most instances, 3D cultures display histological features and differentiated phenotypes that are rarely achieved in 2D cultures [10–12]. The aim of the current study was to establish new 3D models of FTSECs, and to investigate whether 3D FTSEC cultures are more biologically relevant models than monolayer cultures. We developed in vitro 3D cultures of FTSECs that mimic features of fallopian tube epithelia in vivo; the characteristics of these models suggests that they are suitable for studying both the biology of normal fallopian tube epithelial cells and the early-stage development of HGSOCs.

Results

Isolation of fallopian tube secretory epithelial cells

Fallopian tube epithelial cells were isolated from disease-free fallopian tubes of women undergoing partial salpingectomy or total abdominal hysterectomy with bilateral salpingoophorectomy (Table 1). Epithelial cells were harvested from the ampullary regions of fallopian tube samples. Primary cell cultures were confirmed as epithelial by immunofluorescent staining to analyze expression of cytokeratin (Figure 1a). Two of five FTSEC cultures also expressed the gynecological epithelial cell marker CA125. The absence of stromal contaminants was shown by absence of staining for Von Willenbrand Factor VIII, which is expressed by endothelial cells, and the fibroblastic marker fibroblast surface protein (data not shown). Almost all cells in FTSEC cultures expressed the lineage-specific marker PAX8 in the nucleus (Figure 1a), indicating that the cell culture protocol enriched for fallopian tube secretory epithelial cells (FTSECs) [1, 13]. FTSECs also expressed vimentin and laminin (Figure 1a). FTSECs could be successfully subcultured but had a limited lifespan in culture, which is typical of primary cells. Primary FTSECs proliferated for 34–60 days (equating to 10–16 passages in culture) (Figure 1b) at which point cells acquired senescent morphologies and expressed senescence-associated β-galactosidase (data not shown). The modal karyotype for 5/6 cell lines was 46,XX (Figure 1c); one cell line (FTSEC05) displayed an abnormal karyotype of 46, XX, t(6;6) (p21;q21) in all of the 19 cells analyzed, and was therefore excluded from further analyses.

Table 1 Patient information
Full size table
Figure 1
figure1

Characterization of primary FTSEC in vitro cultures. (a) Primary FTSEC cultures maintain expression of markers expressed by fallopian tube secretory epithelia in vivo (arrowheads indicate secretory, non-ciliated cells), the FTSEC cultures express cytokeratins, CA125, basal laminin, vimentin and nuclear PAX8. 90-100% of cells stain positive for PAX8 suggesting fallopian tube ciliated epithelial cells do not proliferate in vitro. Green stain shows positive staining, nuclei are counterstained with DAPI (blue), except in the case of PAX8. (b) Growth curves. FTSECs have a limited in vitro lifespan, as is typical for primary normal cells. (c) Modal karyotypes for 5/6 primary FTSEC cultures were normal and female (46,XX). # Two cells or fewer showed unbalanced structural chromosomal rearrangements or numerical abnormalities.

Full size image

Three-dimensional culturing of FTSECs

Three-dimensional (3D) cultures of FTSECs were established by inoculating cells into polyHEMA-coated tissue culture plastics as previously described for normal and transformed ovarian epithelial cells [14–16]. Within 24 hours of culture, FTSECs aggregated and spontaneously formed multicellular spheroids. After 14 days, FTSEC spheroids were fixed, paraffin-embedded and sectioned, and the histological features examined by hematoxylin and eosin (H&E) staining. All five primary lines grew as spheroids and revealed a similar cellular architecture. A monolayer of epithelial-like cells typically surrounded each spheroid and in some instances there was also multi-layering of the epithelium. FTSEC spheroids commonly displayed a crescent-shaped cellular cap structure, which we have previously described for primary normal ovarian epithelial cell cultures in 3D [14]. The centre of the spheroids comprised a hyaline matrix that resembled the extracellular matrix present in the in vivo tissue in composition (Figures 2 and 3). We observed some viable cells amongst abundant karyorrhectic debri (nuclear dust) within the matrix core of the spheroids. Many of the viable cells within spheroid cores (but not cells on the periphery) exhibited nuclear and cellular pleomorphism, suggesting these cells undergo apoptosis and degenerate (Figure 2a (ii)). In doing so, these cells contribute to the matrix material that makes up the structure of the core of FTSEC spheroids. The internal structure and sub-cellular features of three-dimensional spheroid cultures of FTSECs, examined by transmission electron microscopy revealed features of epithelial cells, including microvilli (Figure 2b (i)), tight junctions (Figure 2b (ii & iii)) and adherens junctions (Figure 2b (iv)).

Figure 2
figure2

Histological analysis of 3D FTSEC spheroids. (a) Three dimensional spheroid cultures stained by hematoxylin and eosin. At (i) 15 days, the core of the spheroids contains abundant matrix material (*), covered by an epithelial cell monolayer (arrow) or cellular cap structure (arrowhead). (ii) After 40 days no viable cells remain within the core of the spheroids. A viable monolayer covers the surface of the spheroid (arrow), degenerate nuclear debris can be seen within the matrix core (arrowhead). (b) Electron microscopy of FTSEC spheroids. Features of epithelial cells in vivo are detected in 3D cultured FTSECs including (i) microvilli and cell-cell junction complexes including (ii,iii) tight junctions (white arrows and inset) and (iv) adherens junctions (white arrows and inset). Electron microscopy.

Full size image
Figure 3
figure3

Immunohistochemical staining of 2D and 3D cultured FTSECs and primary fallopian tube tissue. Immunohistochemical staining of p53 (clone Do7) and a proliferation marker, MIB1, shows high expression of both markers in 2D cultured cells but low expression in 3D FTSEC cultures (at day 15), and fallopian tube epithelia in vivo. Laminin and vimentin are expressed in 2D cultured cells, 3D cultured cells and in vivo. Expression of fibronectin and collagen I was lower in 2D cultured cells than 3D cultures and fallopian tube epithelia in fresh tissue specimens. Collagen IV is predominantly expressed in the basal lamina (arrow) and stroma of fallopian tubes but was expressed at high levels by 2D cultured cells. Expression of this marker was low/absent in 3D cultured cells. * Fibronectin, collagen I and collagen IV were also examined in FTSEC01, expression patterns were highly similar to data for FTSEC283 and FTSEC03. Expression of collagen IV was restricted to the basal lamina and stroma. None of the markers examined were differentially expressed by ciliated and secretory fallopian tube epithelial cells in vivo. As our cell isolates were predominantly PAX8 positive (Figure 1), we do not expect ciliated cells to be present in the FTSEC spheroid cultures. Brown stain denotes positive antigen detection, cells are counterstained with eosin (blue). Light microscopy. Scale bars = 100 μm.

Full size image

We compared molecular features between 2D and 3D FTSEC cultures using immunohistochemistry for series of biomarkers either known to be expressed in normal fallopian tube epithelia or relevant to the biology of FTSECs in serous carcinogenesis (Figure 3, Table 2). FTSECS are not highly proliferative in vivo, but have high proliferative indices when cultured as a monolayer (Figure 1b and Figure 3). MIB1, which is expressed during G1, S, G2 and M phases of the cell cycle, and p53, which is expressed at the G2/M cell cycle checkpoint both showed marked reductions in expression in 3D cultured FTSECs compared to 2D cultures, suggesting that FTSECs are less proliferative in 3D compared to 2D (Figure 3 and Table 2). This is consistent with the expression of these markers in vivo. PAX8 and E-Cadherin showed no reproducible changes in expression in 2D compared to 3D cultures. Vimentin showed higher expression in 2D cultured cells and in primary tissue, but showed a modest reduction in expression in 3D for all cell lines examined. The basement membrane protein laminin was expressed at high levels in both 2D and 3D cultures. Fibronectin and collagen I were expressed at high levels by epithelial cells of the fallopian tube; these markers were expressed at low levels in 2D FTSEC cultures and were then upregulated in 3D. Collagen IV expression was restricted to the basal lamina and stroma of human fallopian tube tissues but was ectopically expressed at high levels in 2D cultures and then reduced in 3D cultures, which is more reflective of human tissues. One cell line (FTE283) showed increased expression of mucins (mucin 1 and mucin 16, also known as CA125) in 3D cultures, but for the other cell lines these mucins were either expressed at low levels (in 2D cultures) or not all (in 3D cultures).

Table 2 Summary of immunohistochemical staining of FTSEC spheroids
Full size table

Whole transcriptome analyses of FTSECs

We profiled the genes and pathways differentially expressed when FTSECs transition from a 2D to 3D microenvironment. Three FTSEC lines were cultured as 2D monolayers and 3D spheroids for 4 days and whole transcriptome profiling performed using the Illumina HT12 beadchip microarrays. In total, 1005 probes were differentially expressed between 2D and 3D cultures (SAM analysis, FDR = 5.80×10-5, two-class unpaired test, δ = 5.16). Figure 4 shows a heatmap of the top 100 significantly changing genes between 2D and 3D cultures (also listed in Additional file 1: Table S1). Among the most significantly down-regulated genes were those coding for membrane proteins (MARCH4, fold change (FC) 0.065; TMEM106C, FC = 0.22), DNA repair proteins (RAD51C, represented by 2 probes showing fold changes of 0.44 and 0.46) and Rho signaling proteins (DIAPH3, FC = 0.13; CDC42EP3, FC = 0.16). Genes that were up-regulated in 3D cultured cells included those coding for ATP-binding cassette transporters (ABCC3, FC = 4.19; ABCA2, FC = 3.24) and trans-membrane proteins (TMTC1, FC = 1.97; TMCO3, FC = 2.05; TMEM117, FC = 2.19) (Table 3). Hierarchical clustering of Elucidean distances between samples showed that the differences were greater between 2D and 3D culture conditions than for FTSECs from different patients (Figure 4). The three most significantly up- and down-regulated genes were validated by qPCR (Additional file 2: Figure S1 and Figure 5). MARCH4 and DIAPH3 were significantly downregulated in 3D cultured cells compared to 2D cultures (P > 0.05, Figure 5a,b). GINS4 showed a similar trend although changes in expression in 2D versus 3D were not statistically significant (Figure 5c). C11orf96, OLFM2A and LRRK2 were consistently overexpressed in 3D cultured cells compared to the same cells cultured in 2D (Figure 5d-f, P > 0.05).

Figure 4
figure4

Gene expression microarray analysis of 2D and 3D cultured FTSECs. Hierarchical clustering of transcriptomic profiles of the 100 genes showing the most significant changes in expression between three 2D and 3D cultured FTSEC primary lines. Three independent samples were prepared for each cell line and each culture condition, each sample represents an individual microarray, technical replicates are shown. Cell lines cluster according to culture conditions, not patient.

Full size image
Table 3 Analysis of gene ontology terms over-represented in 3D cultured cells
Full size table
Figure 5
figure5

Validation of genes identified through expression microarray profiling of 2D and 3D cultured FTSECs. The most significantly changing genes were validated by TaqMan qPCR in independent 2D and 3D cultures of FTSEC03, as well as in two additional cell lines from different patients (FTSEC01 and FTSEC284). Genes downregulated in 3D cultured cells (a) MARCH4 and (b) DIAPH3 were significantly downregulated in all 3 cell lines tested with the exception. (c) A similar trend was observed for GINS4 although this did not reach statistical significance. Genes upregulated in 3D cultured cells (d) C11orf96, (e) OLFM2A and (f) LRRK2 were all upregulated in all 3 samples following a transition to a 3D microenvironment. * P > 0.05, ** P > 0.01, *** P > 0.001, two-tailed paired Student’s T-tests were used to compare 2D and 3D cultured cells for each cell line individually.

Full size image

We performed gene ontology (GO) analyses using the top 1005 probes representing 821 unique Entrez identifiers. For a sub-set of 354 identifiers that were significantly downregulated in 3D cultures, 80 GO terms were significantly over-represented; 75% of these were associated with cell division, mitosis, telomere maintenance, DNA replication and repair (Table 3). The most significantly over-represented term was organelle fission (P = 2.00×10-25). Positive regulation of transcription from RNA polymerase II promotor was the only GO term significantly over-represented in the 467 identifiers that were overexpressed in 3D cultures (Table 3), which is likely to reflect the widespread changes in gene expression observed when FTSECs transition from a 2D to 3D microenvironment. No GO terms were found to be under-represented in the 1005 probes that significantly different in the comparison of 2D and 3D FTSEC cultures.

We took two approaches to examine whether 3D culturing of FTSECs affects functional differentiation. Firstly we examined expression of genes that encode proteins known to be secreted by FTSECs in vivo: oviduct specific glycoprotein 1 (OVGP1), pregnancy-associated plasma protein A (PAPPA) and tissue factor pathway inhibitor 2 (TFPI2, also known as placental protein 5). OVGP1 and PAPPA were significantly upregulated by all 3 FTSEC cultures following the transition to 3D (P > 0.05, Figure 6a). TFPI2 was also significantly upregulated in 2/3 3D cultures (P > 0.05). Secondly, we compared gene expression profiles of 2D and 3D FTSEC cultures with profiles of fresh human fallopian tube tissue specimens. Datasets representing fallopian tube epithelial tissues harvested at different points of the menstrual cycle were selected (Tone et al. and George et al. [17, 18]). We used cluster analysis to examine the similarities between global transcriptomic profiles of 2D cultured FTSECs, 3D cultured FTSECs, luteal phase fallopian tube epithelial cells and follicular phase fallopian tube epithelial cells. Regardless of the clustering method used (maximum or Euclidean distance, calculated from either the Pearson or Spearman correlation coefficients), profiles from 2D cultures clustered with fallopian tube epithelial tissues collected during the follicular phase of the menstrual cycle, whilst 3D-cultured cells consistently clustered with luteal phase fallopian tube epithelium (Figure 6b and Additional file 3: Figure S2).

Figure 6
figure6

FTSEC biomarker expression in 2D and 3D and cluster analysis comparing genome-wide transcriptomic profiles of 2D and 3D cultured FTSECs to follicular and luteal phase fallopian tube epithelium. (a) Expression of FTSEC biomarkers is typically higher in 3D than in 2D (i) oviductal glycoprotein 1, (ii) pregnanacy-associated plasma protein A and (iii) tissue factor pathway inhibitor 2. (b) Euclidean Pearson clustering analyses reveal that 2D cultured FTSECs cluster with follicular phase fallopian tube epithelium, whereas 3D cultured fallopian tube epithelial cells cluster with luteal phase tubal epithelium. Each point on the graph indicates an individual microarray profile, technical replicates of cultured cells are shown by colored circles, open circles denoting 2D cultured cells and closed circles denoting 3D cultured FTSECs. Black open circles indicate follicular phase fallopian tube epithelial samples, closed circles indicate luteal phase fallopian tube epithelium. Each point represents an individual patient. All patients from Georges et al. and Tone et al. [17, 18] datasets are shown.

Full size image

Discussion

Here, we describe a novel approach to model normal primary fallopian tube secretory epithelial cells (FTSECs) in an in vitro three-dimensional (3D) spheroid system. Culturing FTSECs as spheroids restores the 3D architecture of the tissue in vivo, as well as gradients of nutrients, oxygen, carbon dioxide and other macromolecules. We observed molecular and cellular features of FTSECs cultured in 3D more closely resembled fresh FTSEC tissue samples than monolayer cultured fallopian tube secretory epithelial cells. One striking change associated with the transition to 3D was the reduced proliferation rate of cells in 3D compared to 2D, as demonstrated by MIB1 and p53 staining. Cells in 3D were less proliferative which was also reflected in the changing patterns of gene expression following transition from 2D to 3D. This is consistent with a previous study of normal ovarian surface epithelial cells cultured in 3D cultures [14], and is also true for normal breast cells [19]. Since proliferation of the fallopian tube mucosa occurs in pre-malignant or malignant lesions [20], these data suggest that these 3D models more closely reflect the quiescent status of normal FTSECs in vivo and are more biologically relevant models of normal FTSECs than 2D monolayers for studying normal fallopian tube biology and tumorigenesis. Furthermore, 3D culturing enhanced the production of secretory products by FTSECs. Oviduct specific glycoprotein 1 (OVGP1), also known as mucin 9, is normally secreted by non-cilated tubal epithelia and improves in vitro fertilization rates by reducing polyspermy and increasing blastocyst formation rates [21, 22]. We found OVGP1 to be upregulated ~2-4 fold in FTSECs cultured in 3D. Similarly, a second glycoprotein, pregnancy associated plasma protein A (PAPPA) was also significantly upregulated in 3D. Increased expression of these bioactive glycoprotein molecules suggests FTSECs grown in 3D have enhanced functional differentiation compared to their 2D counterparts.

We compared global expression profiles of 2D and 3D cultured cells with biomarker expression in primary fresh fallopian tube tissue samples. We showed that gene profiles in 2D cultured cells cluster with follicular phase fallopian epithelial tissue, whereas 3D cultured cells cluster with luteal phase fallopian tube samples. This result may also be driven by the proliferative signature of the 2D cultured cells, as the follicular phase of the menstrual cycle is the proliferative phase, when raised levels of estradiol stimulate proliferation of the epithelia lining the endometrium and fallopian tube [23]. We found that gene expression profiles of 3D cultured FTSECs cluster with those of luteal phase fallopian tube tissues. This phase of the cell cycle is the secretory phase, which may indicate a commitment to secretory differentiation FTSECs cultured in 3D. Consistent with this, we observed upregulation of an secreted proteins as well as an FTSEC marker (PAX8) when one FTSEC line was cultured in 3D. These data strongly suggest that culturing in 3D enhances functional differentiation of FTSECs to a secretory phenotype.

Previous studies have reported culture of human fallopian tube epithelia ex vivo, on collagen gel and alginate matrices [4, 5]. These models have significantly advanced our ability to model human and murine polarized fallopian tube epithelia in vitro. However, one limitation of ex vivo models is the restricted ability to sub-culture the cells. Using a growth factor rich media we were able to subculture the fallopian tube epithelial cells we isolated. We then selected a spheroid culture method to establish 3D cultures because this approach offers flexibility for downstream molecular analysis, and can be scaled up or down to perform high-throughput molecular screening or large-scale mass cultures. Although we did not supply matrix proteins in the cultures, fallopian tube secretory epithelial cells produced a matrix of which laminin was a major component. Laminin is the major protein in the basal lamina, the aspect of the basement membrane to which epithelial cells are adhered in vivo via integrin-mediated interactions. We hypothesize that altered cell-matrix interactions may contribute to the altered gene expression patterns we observed. While the 3D FTSEC cultures presented here do not recreate the complex convoluted architecture of the lumen of a fallopian tube in vivo, in FTSEC spheroids the epithelial cell-basement membrane interaction is restored. We observed that the outer surface of the spheroid is reminiscent of the lumen of the fallopian tube in that cells are in contact with other mucosal epithelia throughout the lateral domains of the cell, and basal domains of the cells are in contact with a basement membrane-type matrix. In contrast, cells trapped within the spheroid cores are surrounded by matrix, which is an ectopic microenvironment for normal epithelial cells. We hypothesize that this may induce programmed cell death, resulting in the high frequency of apoptotic cell debris observed within the cores but not at the periphery of FTSEC spheroids. Alternatively the physiological conditions within spheroids could have contributed to the changes survival of cells at the centre of the multicellular aggregates, since mathematical modeling suggests that deficiencies in ATP [24], glucose, hydrogen and oxygen [25] may all induce necrotic cell death of cells within spheroid cores.

Many key cellular processes are now known to be differently regulated between 2D and 3D cultures, and various factors can induce differential gene expression in 3D, including altered cell-cell and/or cell-matrix communications, nutrient and oxygen gradients, and reduced rates of proliferation. We propose that the 3D models are more biologically relevant tools of FTSECs than traditional 2D monolayers with which to study fallopian tube epithelial cell biology and pathogenesis. Perhaps the greatest potential for clinical impact of these models will come from their use in studies of tumor initiation. This has become particularly significant since it was established recently that the epithelia lining of the fallopian tube likely represents the cell of origin for a proportion of HGSOCs. HGSOCs bear morphological resemblance to Müllerian epithelia and over 80% of this tumor type overexpress PAX8 [26], an FTSEC marker that can be used to distinguish ovarian serous tumors from other, morphologically similar neoplasms [27, 28]. We identified additional FTSEC biomarkers that represent novel candidate HGSOC biomarkers. These include LRRK2, a gene that encodes a kinase involved in Parkinsons Disease [29, 30]. LRRK2 has not previously been implicated in ovarian cancer development but analyses of The Cancer Genome Atlas (TCGA) data suggests ~3% of primary HGSOCs harbor somatic mutations in this gene [31–33]. Other novel FTSEC biomarkers that are overexpressed in HGSOCs include CELSR3, an atypical cadherin; ABCC3, an ABC transport protein implicated in drug resistance [34]; and CTHRC1, a secreted protein shown to be a candidate biomarker for breast and pancreatic cancer [35, 36]. Analyses of primary HGSOC specimens and sera collected from ovarian cancer patients will be required to determine whether any of these novel biomarkers have clinical utility in the early detection of HGSOC.

While it is now widely accepted that a proportion of HGSOCS originate in the fallopian tube, the early stages of disease development are poorly understood and many questions remain to be answered. Reports show differences in the proportions of ciliated and secretory epithelial cells, marker expression and hormone responsiveness between the epithelia found in fimbrial and ampullary regions of the fallopian tube [23, 37, 38]. However, as yet we do not yet know why FTSECs in the fimbrial region of the fallopian tube are more prone to neoplastic transformation. One hypothesis is that the proximity to the mitogenic environment of the ovarian stroma may influence the phenotype of fimbrial FTSECs. Alternatively the region of transition between FTSECs and ovarian mesothelial-type epithelial cells is inherently more prone to neoplastic transformation. In the future, these 3D models of FTSEC transformation that incorporate common somatic genetic alterations characteristic of HGSOC (BRCA1, p53 [31]) or even recently discovered susceptibility alleles that confer low-risk of EOC in the general population [39–45] will be vital tools in answering some of the key questions regarding EOC initiation and development.

Conclusion

In conclusion we have developed a novel 3D in vitro culture model of fallopian tube secretory cells that represent a precursor tissue of high-grade serous ovarian cancer. The greatest potential clinical use for these models is likely to come from molecular and phenotypic studies of the initiation and early stage development of ovarian cancer leading to the discovery of novel biomarkers for early stage disease detection. These models may also have applications beyond the study of ovarian carcinogenesis, for example for studying the interactions between the fallopian tube epithelium and oocytes or zygotes. Co-culture of fallopian tube epithelial cells has been shown to promote the in vitro development of embryos. In future, novel 3D co-culture methodologies, in which glycoprotein secretion is enhanced, may improve in vitro embryogenesis. Models of benign fallopian tube diseases that are commonly associated with female infertility, such as salpingitis and pelvic inflammatory disease, are also few in number; but the models we describe here could be used to mimic such conditions in vitro and help to improve their diagnosis and treatment. Ultimately, it is hoped that these models will lead to much needed insights into the biology and pathogenesis of fallopian secretory epithelial cells and that this knowledge with be invaluable in increasing our ability to diagnose and treat benign and malignant disease arising in the fallopian tubes.

Methods

Tissue collection and cell culture

Patients scheduled to undergo surgical procedures for benign gynecological conditions (including fibroids, polyps) or total abdominal hysterectomies for endometrial cancer provided informed written consent, prior to surgery, agreeing to participate in the study. This study was performed with permission of the UCL Institutional Ethics Committee. Fallopian tubes were inspected by the operating surgeon and a gynecological pathologist and confirmed to be free of malignancy. The distal ampullary region of the fallopian tube was isolated and dissected open to reveal the lumen. Epithelial cells were harvested by gentle brushing with a sterile cytobrush. All FTSEC cell cultures were maintained in MCDB105:Medium 199 (mixed in a 1:1 ratio) supplemented with 15% fetal bovine serum (Hyclone), 10 ng/ml epidermal growth factor, 0.5 mg/ml hydrocortisone, 5 mg/ml insulin, and 34 mg protein/ml bovine pituitary extract, (all Sigma, St Louis, MO, USA). For growth curves 1 × 105 cells were plated in triplicate. Cultures were passaged and population doublings (PD) calculated using the following formula:

PD = log (total cell number at each passage/initial cell number)/log2.

For analysis of cellular karyotype, cells were taken at a low passage and seeded at low density in a 25 cm2 flask. The karyotypes were analysed by a certified clinical cytogeneticist (TDL genetics, London, UK). The number of chromosomes as well as their length, the position of the centromeres, banding pattern and any other physical characteristics were commented on to give a detailed description of any abnormalities.

Immunofluorescent cytochemistry

Cell monolayers were grown on glass coverslips to of ~80% confluency. Cells were washed with ice cold PBS-Ag (PBS with 0.3% fish skin gelatin, Sigma) and fixed for 10 min in 3% paraformaldehyde, then re-washed with PBS-Ag. Cells were permeabilized with 0.3%v/v Triton X-100 in PBS-Ag, rinsed twice again and blocked with goat serum (Invitrogen, Carlsbad, CA, USA) for 30 min. Primary antibodies were diluted 1:1000 in PBSAg and applied to the cells for 1 hour. After rinsing the antibody, secondary was applied for 20 min in the dark, Alexa Fluor 488-coupled secondary or antibodies (Invitrogen) were used for antigen detection. The coverslips were then rinsed and transferred to labelled slides to add DAPI stain for nuclear staining. The slides were viewed under an Olympus BX64 fluorescence microscope (Olympus, Tokyo, Japan) and images were captured and analyzed using Cytovision Genus 3.6 Software (Leica, Wetzlar, Germany).

Three-dimensional cell culture and immunohistochemistry

Tissue culture vessels were twice coated with a 1.5% of poly-2-hydroxyethyl methacrylate (polyHEMA, Sigma) solution in 95% ethanol, and allowed to dry. Before use, polyHEMA coated plates were washed with sterile PBS. Cells were trypsinised and counted, and 1×105 cells plated into polyHEMA coated P100 dishes in 25 mls complete medium. To fix the 3D cultures, spheroids were collected into a 50 ml falcon tube washed twce in PBS and fixed for 30 mins in neutal-buffered formalin (VWR, West Chester, PA, USA). Fixed 3D cultures were then processed into paraffin blocks, sectioned and stained by immunohistochemistry at UCL Advanced Diagnostics immunocytochemistry service laboratory (UCL, London) and at the Translational Pathology Core Facility at UCLA, Los Angeles, California. Staining was performed using standard immunohistochemical staining techniques with the following antibodies collagen type I (Santa Cruz Biotechnology, Santa Cruz, CA, USA), collagen type 4 (Abcam, Cambridge, MA, USA), laminin (Dako, Glostrup, Denmark), pan-cytokeratin (clone AE1/AE3, Dako), p53 (Do7, Dako) and MIB1 (Dako).

Transmission electron microscopy

FTSECs were grown as 3D spheroids for 4 days, after which cells were harvested by centrifugation and the culture media aspirated. Spheroids were washed with PBS and fixed with ½ strength Karnovsky’s Fixative overnight at 4°C. Spheroids were then rinsed in 0.1 M Cacodylate Buffer for 10mins, post-fixed in 2% Osmium Tetroxide for 1 hour, then rinsed again in 0.1 M Cacodylate Buffer for 10 mins. Blocking was performed by immersing spheroids in 1% Uranyl Acetate for 1 hour; spheroids were washed with distilled water and by dehydrated with 50%, 70%, 85%, 95% ethanol for 10 mins each, the 100% ethanol three times for 10 mins each. Spheroids were immersed 1× in 50:50 Ethanol:Propylene Oxide and 3× in Propylene Oxide for 10 mins each. Spheroids were then transferred to 50:50 Epon:Propylene Oxide for 3 hrs, then placed in a vacuum for 1 hr. The previous step was repeated with 80:20 Epon:Propylene Oxide mix then pure Epon (twice) for 3 hrs and in vacuum for 1 hr. Blocks were finally transferred to a 60°C oven overnight. Blocks were sectioned for Transmission Electron Microscopy and analysed using a JEOL JEM 2100 200 Kv Transmission Electron Microscope (JEOL, Peabody, MA).

Gene expression microarray analysis

RNA was extracted from 2D or 4-day old 3D cultures using the Illustra RNAspin mini kit (GE Heathcare) and microarray analyses performed using the Illumina HT-12 Gene Expression Beadchips (Illumina, San Diego, CA, USA) at the USC Epigenome Centre core facility. Data have been deposited onto the GEO database. Raw data were analysed using methods from the specified Bioconductor [46] packages; beadarray to import and process the raw data from the chip images [47], the BASH algorithm [48] for detecting and managing spatial artefacts; the package limma [49], to implement background correction using negative control probes and quantile signal normalisation using negative and positive control probes [50]. Summary data was exported as log transformed mean values of probe signals. For differential gene expression analysis the log-transformed summary probe expression data were analysed using an implementation of the Signifcance Analysis of Microarrays (SAM) method [51] in the package siggenes. A two-class analysis using a modifed t-statistic was used to identify genes that were differentially expressed according to their culture conditions.

Gene ontology analysis

The R package GOstats was used to identify gene ontology terms that are over/under represented in the differentially expressed genes. An implementation of the Hypergeometric test [52] was performed using the function hyperGTest. This computes Hypergeometric p-values for over or under-representation of each GO term in the specified ontology among the GO annotations for genes of interest. P-values were corrected for multiple testing of the total number of ontology terms, using the method described by Benjamini & Hochberg [53].

Cluster analysis

Gene expression data for human fallopian tube epithelial cells were downloaded from the Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/). The data of Tone et al. and George et al. [17, 18] and were downloaded as raw files from GEO (GSE28044 and GSE12172). These data are profiles for microdissected fallopian tube epithelial cells thus minimizing the chance that contamination by stromal or immune cells could affect the profiles. Unsupervised hierarchical cluster analyses were performed to ascertain the quality of biological replicates and also how the relationships between cell lines and culture conditions impact upon gene expression, as well the similarities between culture conditions and primary tissue samples. Maximum and Euclidean distances were calculated, again in ‘R’, using Spearman’s or Pearson’s correlation on untransformed probe expression values and clustered by Ward’s minimum variance method. The data set supporting the results of this article is available in the GEO repository (http://www.ncbi.nlm.nih.gov/geo/), study identifier GSE51220.

Abbreviations

FTSEC:

Fallopian tube epithelial cell

polyHEMA:

Poly-2-hydroxyethyl methacrylate

3D:

Three-dimensional

2D:

Two-dimensional.

References

  1. 1.

    Kurman RJ, Shih IM: Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer–shifting the paradigm. Hum Pathol. 2011, 42 (7): 918-931. 10.1016/j.humpath.2011.03.003.

  2. 2.

    Bowen NJ, Logani S, Dickerson EB, Kapa LB, Akhtar M, Benigno BB, McDonald JF: Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol. 2007, 104 (2): 331-337. 10.1016/j.ygyno.2006.08.052.

  3. 3.

    Henriksen T, Tanbo T, Abyholm T, Oppedal BR, Claussen OP, Hovig T: Epithelial cells from human fallopian tube in culture. Hum Reprod. 1990, 5 (1): 25-31.

  4. 4.

    Fotheringham S, Levanon K, Drapkin R: Ex vivo culture of primary human fallopian tube epithelial cells. J Vis Exp. 2011, 2728-51

  5. 5.

    Levanon K, Ng V, Piao HY, Zhang Y, Chang MC, Roh MH, Kindelberger DW, Hirsch MS, Crum CP, Marto JA: Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis. Oncogene. 2010, 29 (8): 1103-1113. 10.1038/onc.2009.402.

  6. 6.

    Karst AM, Levanon K, Drapkin R: Modeling high-grade serous ovarian carcinogenesis from the fallopian tube. Proc Natl Acad Sci U S A. 2011, 108 (18): 7547-7552. 10.1073/pnas.1017300108.

  7. 7.

    Ince TA, Richardson AL, Bell GW, Saitoh M, Godar S, Karnoub AE, Iglehart JD, Weinberg RA: Transformation of different human breast epithelial cell types leads to distinct tumor phenotypes. Cancer Cell. 2007, 12 (2): 160-170. 10.1016/j.ccr.2007.06.013.

  8. 8.

    Jones PL, Schmidhauser C, Bissell MJ: Regulation of gene expression and cell function by extracellular matrix. Crit Rev Eukaryot Gene Expr. 1993, 3 (2): 137-154.

  9. 9.

    Aggeler J, Ward J, Blackie LM, Barcellos-Hoff MH, Streuli CH, Bissell MJ: Cytodifferentiation of mouse mammary epithelial cells cultured on a reconstituted basement membrane reveals striking similarities to development in vivo. J Cell Sci. 1991, 99 (Pt 2): 407-417.

  10. 10.

    Streuli CH, Schmidhauser C, Bailey N, Yurchenco P, Skubitz AP, Roskelley C, Bissell MJ: Laminin mediates tissue-specific gene expression in mammary epithelia. J Cell Biol. 1995, 129 (3): 591-603. 10.1083/jcb.129.3.591.

  11. 11.

    Li ML, Aggeler J, Farson DA, Hatier C, Hassell J, Bissell MJ: Influence of a reconstituted basement membrane and its components on casein gene expression and secretion in mouse mammary epithelial cells. Proc Natl Acad Sci U S A. 1987, 84 (1): 136-140. 10.1073/pnas.84.1.136.

  12. 12.

    Streuli CH, Bailey N, Bissell MJ: Control of mammary epithelial differentiation: basement membrane induces tissue-specific gene expression in the absence of cell-cell interaction and morphological polarity. J Cell Biol. 1991, 115 (5): 1383-1395. 10.1083/jcb.115.5.1383.

  13. 13.

    Jarboe EA, Folkins AK, Drapkin R, Ince TA, Agoston ES, Crum CP: Tubal and ovarian pathways to pelvic epithelial cancer: a pathological perspective. Histopathology. 2009, 55 (5): 619-

  14. 14.

    Lawrenson K, Benjamin E, Turmaine M, Jacobs I, Gayther S, Dafou D: In vitro three-dimensional modelling of human ovarian surface epithelial cells. Cell Prolif. 2009, 42 (3): 385-393. 10.1111/j.1365-2184.2009.00604.x.

  15. 15.

    Lawrenson K, Sproul D, Grun B, Notaridou M, Benjamin E, Jacobs IJ, Dafou D, Sims AH, Gayther SA: Modelling genetic and clinical heterogeneity in epithelial ovarian cancers. Carcinogenesis. 2011, 32 (10): 1540-1549. 10.1093/carcin/bgr140.

  16. 16.

    Lawrenson K, Grun B, Benjamin E, Jacobs IJ, Dafou D, Gayther SA: Senescent fibroblasts promote neoplastic transformation of partially transformed ovarian epithelial cells in a three-dimensional model of early stage ovarian cancer. Neoplasia. 2010, 12 (4): 317-325.

  17. 17.

    Tone AA, Begley H, Sharma M, Murphy J, Rosen B, Brown TJ, Shaw PA: Gene expression profiles of luteal phase fallopian tube epithelium from BRCA mutation carriers resemble high-grade serous carcinoma. Clin Cancer Res. 2008, 14 (13): 4067-4078. 10.1158/1078-0432.CCR-07-4959.

  18. 18.

    George SH, Greenaway J, Milea A, Clary V, Shaw S, Sharma M, Virtanen C, Shaw PA: Identification of abrogated pathways in fallopian tube epithelium from BRCA1 mutation carriers. J Pathol. 2011, 225 (1): 106-117. 10.1002/path.2927.

  19. 19.

    Lee GY, Kenny PA, Lee EH, Bissell MJ: Three-dimensional culture models of normal and malignant breast epithelial cells. Nat Methods. 2007, 4 (4): 359-365. 10.1038/nmeth1015.

  20. 20.

    Yanai-Inbar I, Silverberg SG: Mucosal epithelial proliferation of the fallopian tube: prevalence, clinical associations, and optimal strategy for histopathologic assessment. Int J Gynecol Pathol. 2000, 19 (2): 139-144. 10.1097/00004347-200004000-00007.

  21. 21.

    McCauley TC, Buhi WC, Wu GM, Mao J, Caamano JN, Didion BA, Day BN: Oviduct-specific glycoprotein modulates sperm-zona binding and improves efficiency of porcine fertilization in vitro. Biol Reprod. 2003, 69 (3): 828-834. 10.1095/biolreprod.103.016444.

  22. 22.

    Kouba AJ, Abeydeera LR, Alvarez IM, Day BN, Buhi WC: Effects of the porcine oviduct-specific glycoprotein on fertilization, polyspermy, and embryonic development in vitro. Biol Reprod. 2000, 63 (1): 242-250. 10.1095/biolreprod63.1.242.

  23. 23.

    Donnez J, Casanas-Roux F, Caprasse J, Ferin J, Thomas K: Cyclic changes in ciliation, cell height, and mitotic activity in human tubal epithelium during reproductive life. Fertil Steril. 1985, 43 (4): 554-559.

  24. 24.

    Bertuzzi A, Fasano A, Gandolfi A, Sinisgalli C: Necrotic core in EMT6/Ro tumour spheroids: is it caused by an ATP deficit?. J Theor Biol. 2010, 262 (1): 142-150. 10.1016/j.jtbi.2009.09.024.

  25. 25.

    Schaller G, Meyer-Hermann M: Continuum versus discrete model: a comparison for multicellular tumour spheroids. Philos Trans A Math Phys Eng Sci. 2006, 364 (1843): 1443-1464. 10.1098/rsta.2006.1780.

  26. 26.

    Köbel M, Kalloger SE, Boyd N, McKinney S, Mehl E, Palmer C, Leung S, Bowen NJ, Ionescu DN, Rajput A: Ovarian carcinoma subtypes are different diseases: implications for biomarker studies. PLoS Med. 2008, 5 (12): e232-10.1371/journal.pmed.0050232.

  27. 27.

    Tong GX, Devaraj K, Hamele-Bena D, Yu WM, Turk A, Chen X, Wright JD, Greenebaum E: Pax8: a marker for carcinoma of Müllerian origin in serous effusions. Diagn Cytopathol. 2011, 39 (8): 567-574.

  28. 28.

    Laury AR, Hornick JL, Perets R, Krane JF, Corson J, Drapkin R, Hirsch MS: PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol. 2010, 34 (5): 627-635.

  29. 29.

    Gilks WP, Abou-Sleiman PM, Gandhi S, Jain S, Singleton A, Lees AJ, Shaw K, Bhatia KP, Bonifati V, Quinn NP: A common LRRK2 mutation in idiopathic Parkinson’s disease. Lancet. 2005, 365 (9457): 415-416.

  30. 30.

    Di Fonzo A, Rohé CF, Ferreira J, Chien HF, Vacca L, Stocchi F, Guedes L, Fabrizio E, Manfredi M, Vanacore N: A frequent LRRK2 gene mutation associated with autosomal dominant Parkinson’s disease. Lancet. 2005, 365 (9457): 412-415.

  31. 31.

    Network CGAR: Integrated genomic analyses of ovarian carcinoma. Nature. 2011, 474 (7353): 609-615. 10.1038/nature10166.

  32. 32.

    Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E: The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov. 2012, 2 (5): 401-404. 10.1158/2159-8290.CD-12-0095.

  33. 33.

    Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, Sun Y, Jacobsen A, Sinha R, Larsson E: Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013, 6 (269): l1-

  34. 34.

    O’Brien C, Cavet G, Pandita A, Hu X, Haydu L, Mohan S, Toy K, Rivers CS, Modrusan Z, Amler LC: Functional genomics identifies ABCC3 as a mediator of taxane resistance in HER2-amplified breast cancer. Cancer Res. 2008, 68 (13): 5380-5389. 10.1158/0008-5472.CAN-08-0234.

  35. 35.

    Park EH, Kim S, Jo JY, Kim SJ, Hwang Y, Kim JM, Song SY, Lee DK, Koh SS: Collagen triple helix repeat containing-1 promotes pancreatic cancer progression by regulating migration and adhesion of tumor cells. Carcinogenesis. 2013, 34 (3): 694-702. 10.1093/carcin/bgs378.

  36. 36.

    Turashvili G, Bouchal J, Baumforth K, Wei W, Dziechciarkova M, Ehrmann J, Klein J, Fridman E, Skarda J, Srovnal J: Novel markers for differentiation of lobular and ductal invasive breast carcinomas by laser microdissection and microarray analysis. BMC Cancer. 2007, 7: 55-10.1186/1471-2407-7-55.

  37. 37.

    Palter SF, Mulayim N, Senturk L, Arici A: Interleukin-8 in the human fallopian tube. J Clin Endocrinol Metab. 2001, 86 (6): 2660-2667. 10.1210/jc.86.6.2660.

  38. 38.

    Laird SM, Hill CJ, Warren MA, Tuckerman EM, Li TC: The production of placental protein 14 by human uterine tubal epithelial cells in culture. Hum Reprod. 1995, 10 (6): 1346-1351. 10.1093/HUMREP/10.6.1346.

  39. 39.

    Song H, Ramus SJ, Tyrer J, Bolton KL, Gentry-Maharaj A, Wozniak E, Anton-Culver H, Chang-Claude J, Cramer DW, DiCioccio R: A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2. Nat Genet. 2009, 41 (9): 996-1000. 10.1038/ng.424.

  40. 40.

    Bolton KL, Tyrer J, Song H, Ramus SJ, Notaridou M, Jones C, Sher T, Gentry-Maharaj A, Wozniak E, Tsai YY: Common variants at 19p13 are associated with susceptibility to ovarian cancer. Nat Genet. 2010, 42 (10): 880-884. 10.1038/ng.666.

  41. 41.

    Goode EL, Chenevix-Trench G, Song H, Ramus SJ, Notaridou M, Lawrenson K, Widschwendter M, Vierkant RA, Larson MC, Kjaer SK: A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24. Nat Genet. 2010, 42 (10): 874-879. 10.1038/ng.668.

  42. 42.

    Bojesen SE, Pooley KA, Johnatty SE, Beesley J, Michailidou K, Tyrer JP, Edwards SL, Pickett HA, Shen HC, Smart CE: Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer. Nat Genet. 2013, 45 (4): 371-384. 10.1038/ng.2566. 384e371-372

  43. 43.

    Permuth-Wey J, Lawrenson K, Shen HC, Velkova A, Tyrer JP, Chen Z, Lin HY, Chen YA, Tsai YY, Qu X: Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31. Nat Commun. 2013, 4: 1627-

  44. 44.

    Pharoah PD, Tsai YY, Ramus SJ, Phelan CM, Goode EL, Lawrenson K, Buckley M, Fridley BL, Tyrer JP, Shen H: GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer. Nat Genet. 2013, 45 (4): 362-370. 10.1038/ng.2564. 370e361-362

  45. 45.

    Shen H, Fridley BL, Song H, Lawrenson K, Cunningham JM, Ramus SJ, Cicek MS, Tyrer J, Stram D, Larson MC: Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer. Nat Commun. 2013, 4: 1628-

  46. 46.

    Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J: Bioconductor: open software development for computational biology and bioinformatics. Genome Biol. 2004, 5 (10): R80-10.1186/gb-2004-5-10-r80.

  47. 47.

    Kuhn K, Baker SC, Chudin E, Lieu MH, Oeser S, Bennett H, Rigault P, Barker D, McDaniel TK, Chee MS: A novel, high-performance random array platform for quantitative gene expression profiling. Genome Res. 2004, 14 (11): 2347-2356. 10.1101/gr.2739104.

  48. 48.

    Cairns JM, Dunning MJ, Ritchie ME, Russell R, Lynch AG: BASH: a tool for managing BeadArray spatial artefacts. Bioinformatics. 2008, 24 (24): 2921-2922. 10.1093/bioinformatics/btn557.

  49. 49.

    Smyth GK: Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004, 3: Article3-

  50. 50.

    Shi W, Oshlack A, Smyth GK: Optimizing the noise versus bias trade-off for Illumina whole genome expression BeadChips. Nucleic Acids Res. 2010, 38 (22): e204-10.1093/nar/gkq871.

  51. 51.

    Tusher VG, Tibshirani R, Chu G: Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci U S A. 2001, 98 (9): 5116-5121. 10.1073/pnas.091062498.

  52. 52.

    Alexa A, Rahnenführer J, Lengauer T: Improved scoring of functional groups from gene expression data by decorrelating GO graph structure. Bioinformatics. 2006, 22 (13): 1600-1607. 10.1093/bioinformatics/btl140.

  53. 53.

    Benjamini Y, Hochberg Y: Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Stat Soc Ser B. 1995, 1 (51): 298-300.

Download references

Acknowledgements

This research was performed at the Keck School of Medicine, University of Southern California, Los Angeles, California, USA, and at the Institute for Women’s Health, University College London, UK. Electron microscopy was performed at the USC/Norris Cancer Center Cell and Tissue Imaging Core Facility and gene expression microarrays were performed at the USC Epigenome Centre Core facility. The content of this article is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute or the National Institutes of Health.

Grant support

KL is funded by National Institute of Health grant 5 U19 CA148112-02 and an Ann Schreiber Program of Excellence award from the Ovarian Cancer Research Fund. MN was funded by an MRC studentship. Some of this work undertaken at UCLH/UCL was partly funding from the Department of Health’s NIHR Biomedical Research Centre funding scheme. Part of this research was performed within the USC Norris Comprehensive Cancer Centre (NCI CCSG grant P30CA014089). This work was in part supported by the Genetic Associations and Mechanismsin Oncology (GAME-ON) consortium: a NCI Cancer Post-GWAS Initiative (U19-CA148112).

Author information

Author notes

    Affiliations

    1. Department of Preventive Medicine, University of Southern California/Keck School of Medicine, 1450 Biggy Street, Los Angeles, California
      • Kate Lawrenson
      • , Nathan Lee
      •  & Simon A Gayther
    2. Gynaecological Cancer Research Laboratories, UCL EGA Institute for Women’s Health, University College London, The Paul O’Gorman Building, Gower Street, London, WC1E 6DD, UK
      • Maria Notaridou
      •  & Christopher Jones
    3. Department of Histopathology, Cancer Institute, University College London, Rockefeller Building, University Street, London, WC1E 6JJ, UK
      • Elizabeth Benjamin
    4. Faculty of Medical and Human Sciences, 1st Floor, Innovation Centre, Core Technology Facility, The University of Manchester, 46 Grafton Street, Manchester, M13 9NT, UK
      • Ian J Jacobs
    Authors
    1. Kate Lawrenson
      View author publications
      You can also search for this author in
    2. Maria Notaridou
      View author publications
      You can also search for this author in
    3. Nathan Lee
      View author publications
      You can also search for this author in
    4. Elizabeth Benjamin
      View author publications
      You can also search for this author in
    5. Ian J Jacobs
      View author publications
      You can also search for this author in
    6. Christopher Jones
      View author publications
      You can also search for this author in
    7. Simon A Gayther
      View author publications
      You can also search for this author in

    Corresponding author

    Correspondence to Simon A Gayther.

    Additional information

    Competing interests

    The authors declare that they have no competing interest.

    Authors’ contributions

    KL and SAG designed the study and wrote the manuscript. KL, MN and NL performed the experiments. EB provided pathology expertise. CJ analyzed the microarray data. All authors read and approved the final manuscript.

    Kate Lawrenson, Maria Notaridou contributed equally to this work.

    Electronic supplementary material

    Additional file 1: Table S1: Gene expression microarray analysis of gene expression changes associated with transfer of fallopian tube secretory epithelial cells (FTSECs) from a 2D to a 3D microenvironment. The 100 most significantly changing genes in 3D cultured FTSECs compared to 2D cultured FTSECs. 53 genes were significantly upregulated, 47 genes were significantly downregulated. (XLSX 21 KB)

    Additional file 2: Figure S1: Validation of genes identified as differentially expressed in 2D and 3D cultured FTSECs. We validated the top 3 up- and downregulated genes by qPCR. (JPEG 94 KB)

    Additional file 3: Figure S2: Cluster analyses comparing genome-wide transcriptomic profiles of 2D and 3D cultured FTSECs to follicular and luteal phase fallopian tube epithelium. Each point on the graph indicates an individual microarray profile, technical replicates of cultured cells are shown by colored circles, open circles denoting 2D cultured cells and closed circles denoting 3D cultured FTSECs. Black open circles indicate follicular phase fallopian tube epithelial samples, closed circles indicate luteal phase fallopian tube epithelium. Each point represents an individual patient. All patients from Georges et al. and Tone et al. [17, 18] datasets are shown. Clustering is consistent regardless of cluster method used (a) Euclidean Spearman, (b) maximum Pearson and (c) maximum Spearman. (JPG 56 KB)

    Authors’ original submitted files for images

    Rights and permissions

    Reprints and Permissions

    About this article

    Cite this article

    Lawrenson, K., Notaridou, M., Lee, N. et al. In vitro three-dimensional modeling of fallopian tube secretory epithelial cells. BMC Cell Biol 14, 43 (2013). https://doi.org/10.1186/1471-2121-14-43

    Download citation

    Keywords

    • Fallopian tube secretory epithelial cells
    • Gene expression microarray
    • Three-dimensional in vitro models
    • Tissue microenvironment
    • Ovarian cancer

    BMC Molecular and Cell Biology

    ISSN: 2661-8850

    Contact us